NCT00006440

Completed

A Test of Behavioral Intervention for Women at High Risk for...

National Institute of Allergy and Infectious Diseases (NIAID)Source

Compare

Other study identifiers

Sponsor study identifier

HIVNET 029

Study Type

observational

Reported enrollment (type unavailable)

180

Locations

1 country

Sites

1

Timeline

Study Start

March 2000

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

May 2008

Actual (reported)

Study Completion

May 2008

Actual (reported)

Brief Summary

The purpose of this study is to find out if it is possible to conduct a group counseling program for women at risk for HIV infection. Women have been the fastest-growing group with new AIDS diagnoses. The need for ways to reduce HIV infection in women is urgent. It is important to reduce the risk of HIV infection through sexual contact, but it is also important to address drug use. Group counseling may be an effective method.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Reported enrollment (type unavailable): 180 participants
Study completion date: May 2008
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2000
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
November 3, 2000
Actual (reported)
First Posted
August 31, 2001
Actual (reported)
Primary Completion
May 2008
Actual (reported)
Study Completion
May 2008
Actual (reported)

Last Updated: October 31, 2016
Status Verified: October 2012
Last Update Submitted: October 27, 2016

Conditions

HIV Infections

Keywords

Risk FactorsBehavior TherapySubstance-Related DisordersFeasibility Studies

Eligibility Criteria

Age18 Years+

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Women may be eligible for this study if they:
Are at least 18 years old.
Took part in the VPS2 study and completed 12 months of follow-up, or each participant must meet at least 1 of the following conditions: 1) has sex with an HIV-infected male; 2) has sex with a male who has injected drugs in the last 5 years; 3) has had sex with 5 or more male partners in the last year; 4) exchanged sex for money or drugs in the last year; 5) was diagnosed with syphilis, chlamydia, gonorrhea, first episode herpes, pelvic inflammatory disease, and/or trichomonas in the last year; or 6) used crack cocaine in the last year.
Can speak English.

Sponsors & Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)
NIHlead

Study Sites (1)

Anne Colletti

Cambridge, Massachusetts, 02138, United States

MeSH Terms

Conditions

HIV InfectionsSubstance-Related Disorders

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Study Officials

Erica Gollub
STUDY CHAIR

Study Design

Study Type: observational
Sponsor Type: NIH
Responsible Party: SPONSOR

Study Record Dates

First Submitted

November 3, 2000

First Posted

August 31, 2001

Study Start

March 2000

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

May 2008

Actual (reported)

Vaccine (ALVAC-HIV vCP1452) Use and Intermittent Withdrawal of Anti-HIV Drugs in Patients With HIV

Phase 1/2Completed

NCT00073229

Immune Function of Infants With HIV

Completed

NCT00000940

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Phase 2Completed

NCT00006441

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Not ApplicableCompleted

NCT00000931

HIV Prevention Counseling for Men Who Have Sex With Men

Phase 3Completed

NCT00000932

A Study of the Long-Term Outcomes of HIV-Positive Patients

Completed

Can give information for the purpose of locating.

Have had at least 30 percent of vaginal or anal intercourse unprotected by condoms in the 6 months before the study.

Are HIV-negative.

You may not qualify if:

Women will not be eligible for this study if they:
Have had sex with only 1 man for 2 years or more who is HIV-negative and does not inject drugs. The man should not have had sex with anyone else during this time.
Have a mental condition that would interfere with the study.
Have any other condition that would interfere with the study.

Contact the study team to confirm eligibility.

Chemically-Induced Disorders

Mental Disorders

Study Completion

May 2008

Actual (reported)

Last Updated

October 31, 2016

Record last verified: 2012-10

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00006440
Data provider: ClinicalTrials.gov
Source updated: 2016-10-31
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:25:14 UTC

Locations

US(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations